ITALY – MPS backs EUR 6m PharmEste funding

Headquartered in Ferrara, PharmaEste was founded in 2003 as a spin-off from the local university. It carries out research on neuropathic pain developing molecules that can be integrated with Transient Receptor Potential Vanilloid-1 to produce therapeutic treatments.

The company closed a EUR 3.2m series-A financing round in January 2007, which included contributions from Z-Cube, Quantica, Zernike Meta Venture and State Street Global Investments (now known as Fondamenta).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• Southern Europe
• Healthcare